Ledger.Open graph →
SEC Form D · filed February 20, 2025

Ibex Biosciences, Inc

Offering
$12.5M
Sold
$70K
Exemption
Rule 506(c)
Industry
Biotechnology
Location
Rockville, MD
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (11)

Michael J. Karlin · Bethesda, MDExec · DirectorRoy J. Feinson · Washington, Washington, D.C.DirectorSylvan I. Karlin · Bethesda, MDDirectorAlberto M. Croci · CHEVY CHASE, MDExec · DirectorMarc Swerdlow · GLENDALE, COExec · DirectorJaimee Desai · Southbank, Channel IslandsDirectorMichael Block · New York, NYDirectorKatharine Wolanyk · Chicago, ILExec · DirectorKatrina E. Romatowski · Seattle, WADirectorAnupam Rastogi · San Francisco, CADirectorAlberto M. Croci · CHEVY CHASE, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗